[Effects of antiatherosclerosis diet including soy protein on the dynamics of clinical, biochemical and immunologic indicators in patients with ischemic heart disease and hypertension].

[The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Vopr Pitan (2012) 0.81

[Comparative study of effects of diet therapy including eiconol or linseed oil on several parameters of lipid metabolism in patients with type 2 diabetes mellitus]. Vopr Pitan (2001) 0.80

[The clinical and experimental research of metabolic effects of shark liver oil]. Vopr Pitan (2007) 0.78

[Clinical use of flavonoid enriched biologically active food supplements in patients with chronic atrophic gastritis in combination with chronic cholecystitis or bile ducts dyskinesia]. Vopr Pitan (2003) 0.78

[The effect of diet with the sour-milk product enriched with amaranth on parameters of antioxigen protection at patients with a cardiovascular pathology]. Vopr Pitan (2004) 0.77

[Influence of dietary therapy containing sunflower oil fortified with phospholipids on the lipid metabolism in patients with hypertension and obesity]. Vopr Pitan (2007) 0.77

[Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet]. Vopr Pitan (1997) 0.76

[Immune and metabolic effect of polyunsaturated fatty acids omega 3 in anti-atherosclerotic diet in the treatment of patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76

[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76

[Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76

[Degradation of endo- and exogenous albumin in normal and starved rats]. Vopr Med Khim (1993) 0.76

[Effects of diet therapy including eiconol on clinical and metabolic parameters in patients with type 2 diabetes mellitus]. Vopr Pitan (2000) 0.76

[Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance]. Vopr Pitan (2000) 0.76

[Effects of a diet including linseed oil on clinical and metabolic parameters in patients with type 2 diabetes mellitus]. Vopr Pitan (2000) 0.76

[Effects of anti-atherosclerosis diet containing omega 3 fatty acids on the lipid spectrum of blood and cell membranes in patients with ischemic heart disease and essential hypertension]. Vopr Pitan (1991) 0.76

[The effect of an antiatherosclerotic diet including omega-3 polyunsaturated fatty acids of marine and plant origins on the indices of cellular and humoral immunity in patients with ischemic heart disease and a disordered carbohydrate tolerance]. Vopr Pitan (2000) 0.76

[Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia]. Vopr Pitan (1997) 0.76

[Effect of selenium enriched diet on lipid peroxidation in patients with diabetes mellitus type 2]. Vopr Pitan (2003) 0.76

[The study of the clinical potency of antiatherogenic diet containing flavonoids in cardiovascular patients]. Vopr Pitan (2003) 0.75

[Effect of antiatherosclerotic diet, containing polyunsaturated fatty acids of the omega-3 family from flax oil, on fatty acid composition of cell membranes of patients with ischemic heart disease. Hypertensive disease and hyperlipoproteinemia]. Vopr Pitan (1997) 0.75

The Health and Functioning ICF-60: development and psychometric properties. Clin Psychol Psychother (2014) 0.75

[The effect of diets containing omega-3 polyunsaturated fatty acids on biochemical indicators and the fatty acid composition of the cell membranes in patients with ischemic heart disease and hereditary hyperlipidemia]. Vopr Med Khim (1992) 0.75

[Analysis of modern concepts concerning the role of processed soybean products in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[Effect of dietotherapy on thrombocyte lysosomal hydrolase activity in patients with hyperlipidemia and ischemic heart disease]. Patol Fiziol Eksp Ter (1987) 0.75

[Use of phytoestrogens in medicine]. Vopr Pitan (2003) 0.75

[The effect of diet therapy on the lipolytic activity of the adipose tissue and serum in patients with ischemic heart disease and excessive body weight]. Ter Arkh (1983) 0.75

[Peculiarity mineralization of osteous tissue of patients wits cardiovascular and gastroenteric pathologic and provision with vitamins and calcium]. Vopr Pitan (2008) 0.75

[Evaluation of the effects of fish and vegetable omega-3 PUFA complex on the erythrocyte fatty acid composition in patients with ischemic heart disease and impaired glucose tolerance]. Vopr Pitan (1999) 0.75

[Dietary fibers in diet therapy]. Vopr Pitan (1998) 0.75

[Marine fish oil in the prevention and treatment of cardiovascular diseases]. Vestn Ross Akad Med Nauk (1996) 0.75

[Activity of phospholipases A in the adipose tissue and adipocytes in obesity and ischemic heart disease]. Ter Arkh (1982) 0.75

[The study of polymorphism rs9939609 FTO gene in patients with overweight and obesity]. Vopr Pitan (2011) 0.75

[Antioxidant level and lipid metabolism in patients with cardiovascular disease]. Vopr Pitan (2007) 0.75

[Homocysteine as a coronary risk factor]. Vopr Pitan (2003) 0.75

[Efficiency of diet therapy containing carbohydrate-protein product enriched with vitamins and minerals in patients with cardiovascular diseases, obesity, and osteopenia]. Vopr Pitan (2008) 0.75

[The study of FTO rs9939609-gene polymorphism in the Sverdlovsk Region]. Vopr Pitan (2012) 0.75

[Effects of diet containing polyunsaturated fatty acids omega-3 and different doses of vitamin E on the activity of lipid peroxidation in patients with hypertension]. Vopr Pitan (1995) 0.75

[Effects of biologically active supplements on the antioxidant and vitamin status of patients with hypertension and ischemic heart disease]. Vopr Pitan (2001) 0.75

[Clinico-metabolic effects of fish oil in patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.75

[Fat and content of yakutan horse fat tissue]. Vopr Pitan (2005) 0.75

[Effect of clofibrate on the enzyme activity of liver and adipose tissue lysosomes in the rat in the presence of an unbalanced fatty component in the diet]. Patol Fiziol Eksp Ter (1984) 0.75

[Cholesterol metabolism in patients with ischemic heart disease with varying supplies of omega-3 polyunsaturated fatty acids]. Vopr Med Khim (1995) 0.75

[Peculiarities of vitamin status in men and women with cardiovascular disease and obesity]. Vopr Pitan (2012) 0.75

[The study of soy isoflavone metabolism in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75

[Thrombocyte lysosomal hydrolase activity in patients with ischemic heart disease, hyperlipidemia and obesity against a background of different diets]. Vopr Pitan (1988) 0.75

[Comparative study on the effect of antiatherosclerotic diet enriched with polyunsaturated omega-3 fatty acids of plant and animal origin on the level of natural antibodies against catecholamines in patients with cardiovascular diseases]. Vopr Pitan (1998) 0.75

[Influence of chitosan on clinical-biochemical rates and protein metabolism of patients with cardiovascular diseases]. Vopr Pitan (2008) 0.75

[Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia]. Vopr Pitan (2003) 0.75

[Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases]. Vopr Pitan (1998) 0.75

[Effect of neonatal nutrition on the enzyme activity of liver lysosomes, adipocytes and thrombocytes in young and old rats]. Vopr Pitan (1986) 0.75

[Dietary fiber influence on vitamins assimilation in patients suffering from cardiovascular diseases and adiposity]. Vopr Pitan (2010) 0.75

[Determination of natural antibodies to catecholamines in health and disease]. Ter Arkh (1998) 0.75

[Definite of nutritional status in patients with metabolic syndrome with the use of modern methods of nutrimetabolomica]. Vopr Pitan (2010) 0.75

[Clinico-biochemical evaluation of the effectiveness of diet therapy in gastroenterologic patients]. Vopr Med Khim (1991) 0.75

[The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan (2006) 0.75

[Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases]. Vopr Pitan (1997) 0.75

[Genetic approaches to nutrition personalization]. Vopr Pitan (2012) 0.75

[Study of fatty acid composition of cell membranes during the use of soya oil in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[Current views of nutritional therapy]. Klin Med (Mosk) (2009) 0.75

[Study of the state of lipid peroxidation system: antioxidant protection during the use of soy oil in patients with ischemic heart disease and hypertension]. Vopr Pitan (2000) 0.75

[Energy metabolic in patients with ischemic heart disease before and after heart surgery]. Vopr Pitan (2007) 0.75

[Comparative evaluation of hypolipidemic effects of omega-3 polyunsaturated acids and lipostabil]. Vopr Pitan (1996) 0.75

[Effect of atherosclerotic diet containing polyunsaturated omega-3 fatty acids on level of natural antibodies to prostaglandin F2alpha in patients with ischemic heart disease, hyperlipidemia and hypertension]. Vopr Pitan (1994) 0.75

[The use of natural phytosterins for correction of abnormalities of lipid metabolism]. Kardiologiia (2011) 0.75

[Dynamics of the natural antibody level as affected by the biologically active food supplement "Vitol" in patients with hypertensive disease and obesity]. Vopr Pitan (1999) 0.75

[Use of fish oil enriched with carotenoids isolated from sea cucumbers in the diet therapy of patients with hypertension and ischemic heart disease]. Vopr Pitan (2003) 0.75

[Correction of mineral metabolism impairment with an allowance for seasonal fluctuations in patients with ischemic heart disease and hypertensive disease with overweight]. Vopr Pitan (2001) 0.75

[Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates]. Klin Med (Mosk) (2003) 0.75

[Effect of an anti-atherogenic diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension and ischemic heart disease]. Vopr Pitan (2002) 0.75

[Lipid peroxidation upon the use of omega-3 polyunsaturated fatty acids in the treatment of hypertension and ischemic heart disease]. Vopr Med Khim (1992) 0.75

[The effect of omega-3 polyunsaturated fatty acids on the clinico-biochemical indices and kidney nitrogen-excreting function in patients with chronic kidney failure]. Vopr Pitan (1993) 0.75

[Vitamin status and bone mineral density at patients with adiposity and the cardiovascular pathology]. Vopr Pitan (2008) 0.75

[Evaluation of dietary therapy efficiency, based on clinical and biochemical parameters in patients with cardiovascular disease and osteopenia]. Vopr Pitan (2007) 0.75

[Immunoenzyme technique for detection of natural antibodies to bradykinin in cardiovascular diseases]. Klin Lab Diagn (2001) 0.75

[Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity]. Vopr Pitan (2001) 0.75

[Biologically active food supplements in comprehensive therapy of patients with ischemic heart disease and hypertension and the background of overweight]. Vopr Pitan (2000) 0.75

[Experience of phytosterols' application in dietetic cardiovascular diseases]. Vopr Pitan (2008) 0.75

[Study of metabolic and clinical effects of polyunsaturated fatty acids omega-3 from "Eicovit" in patients with ischemic heart disease and familial hyperlipoproteinemia]. Vopr Pitan (1998) 0.75

[The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan (2006) 0.75

[Using diet therapy based on complex assessment of nutritional status in patient with cardiovascular diseases and obesity]. Vopr Pitan (2007) 0.75

[Efficiecy of application assessment of grain bread in diettherapy of patients of elderly ages with cardiovascular diseases]. Vopr Pitan (2006) 0.75

[The use of nutritional antioxidants for the correction of metabolic disorders of cardiovascular patients]. Vopr Pitan (2004) 0.75

[The assessment of clinical efficiency of the diet therapy in cardiosurgery patients]. Vopr Pitan (2007) 0.75

[Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension]. Vopr Pitan (1996) 0.75

[The homeostatic changes of mineral and trace elements during of year at rheumatoid arthritis]. Vopr Pitan (2006) 0.75

[Effect of diet enriched with selenium on the psycho-emotional and adaptive capacity of patients with cardiovascular diseases and obesity]. Vopr Pitan (2012) 0.75

[Multilevel study of actual nutrition in the complex analysis of nutritial status of patients with obesity]. Vopr Pitan (2009) 0.75

[The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases]. Vopr Pitan (2005) 0.75

[The system of multilevel diagnostics and corrections of nutrition status disorders in the patients with cardiovascular diseases]. Vopr Pitan (2009) 0.75

[Effects of polyunsaturated fatty acids of the omega-3 family in the anti-atherosclerotic diet on the activity of lysosomal lipolytic enzymes, mononuclear cells and blood platelets of patients with ischemic heart disease]. Vopr Pitan (1994) 0.75

[Efficacy of the use of a sour milk product enriched with phytosterols in diet therapy of patients with cardiovascular diseases]. Kardiologiia (2008) 0.75

[Clinical efficiency of using laminaria jam enriched with selenium]. Vopr Pitan (2009) 0.75

[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Vopr Pitan (2002) 0.75

[Soybean proteins in correction of coronary risk factors in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75

[Anti-atherosclerotic properties of some components of food (a clinico-experimental study)]. Vopr Pitan (1990) 0.75

[The investigation of influent of antiatherosclerotic diets with inulin on clinical and metabolic parameters in patients with cardiovascular diseases]. Vopr Pitan (2006) 0.75

[Dietary correction of nutrition status in patients with metabolic syndrome]. Vopr Pitan (2009) 0.75